Beta blockers

Pacrinolol is a beta adrenergic receptor antagonist.

Atenolol/chlorthalidone, also known as co-tenidone, is a combination medication used to treat high blood pressure. It is made up of atenolol, a beta-blocker and chlortalidone, a diuretic. It is not recommended as an initial treatment but may be used in those who are taking atenolol and chlortalidone individually. It is taken by mouth.

Falintolol is a beta-adrenergic receptor antagonist.

Desacetylmetipranolol is the active metabolite of metipranolol.

Adimolol (developmental code name MEN-935) is antihypertensive agent which acts as a non-selective α1-, α2-, and β-adrenergic receptor antagonist.

Flestolol is a short-acting beta adrenergic receptor antagonist.

Tienoxolol is a beta adrenergic receptor antagonist.

Iprocrolol is a beta blocker that was never marketed.

Ronactolol is a beta adrenergic receptor antagonist.

Pargolol is a beta adrenergic receptor antagonist.

Procinolol is a beta adrenergic receptor antagonist, a group of pharmaceutical drugs that lower heart rhythm and blood pressure.

Sulfinalol is a beta adrenergic receptor antagonist.

Bornaprolol is a beta-adrenergic antagonist. ==Synthesis== [[File:Bornaprolol synthesis.svg|thumb|center|500px|ChemDrug Synthesis: Patent:]] The reaction between 2-(Bicyclo[2.2.1]hept-2-yl)phenol [17152-43-1] (1) and epichlorohydrin [106-89-8] (2) in the presence of sodium metal gives (3). Opening of the oxirane by treatment with isopropylamine [75-31-0] (4) completed the synthesis of Bornaprolol (5). ==References==

Toliprolol is a beta adrenergic receptor antagonist.

Tolamolol is a beta adrenergic receptor antagonist.

Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma. It is marketed as a 0.25 or 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker).

Soquinolol is a beta adrenergic receptor antagonist.

REDIRECT Propranolol#Idropranolol

Cetamolol is a beta adrenergic antagonist, more specifically a β1-adrenergic blocker.

Hydroxycarteolol is a beta blocker and metabolite of carteolol.

Indopanolol is a beta blocker.

Bufetolol is a beta-adrenoceptor antagonist.

Pamatolol is a beta adrenergic receptor antagonist.

Pafenolol is a beta adrenergic receptor antagonist.

Bucumolol is a beta-adrenergic antagonist.

Tiprenolol is a beta adrenergic receptor antagonist.

Ridazolol is a pharmaceutical drug acting as a beta adrenergic receptor antagonist. It was investigated in the 1980 and 90s for its effects on coronary heart disease and essential hypertension (high blood pressure).

Isoxaprolol is an adrenergic antagonist with antiarrhythmic and antihypertensive properties.

Nipradilol is a beta blocker and nitric oxide donor.

Primidolol is a beta adrenergic receptor antagonist.

Bupicomide is a chemical compound created and manufactured by Lanospharma Laboratories Company, Ltd. It is used experimentally as a beta blocker and clinically as a strong vasodilator with the noted side effects of reduced systolic, diastolic and mean arterial pressure.

Pindobind is a compound developed by researchers associated with Stanford University, identified as a central nervous system depressant, which generated a response in animals reducing offensive actions such as chasing, while also notably reducing tendencies of the test animal to evade when stimulated to do so. It acts as an irreversible beta blocker and irreversible 5-HT1A receptor antagonist.

Alprenoxime is a beta blocker. It is a prodrug to alprenolol.

Spirendolol is a beta adrenergic receptor antagonist.

Medroxalol is a vasodilator beta blocker also classified as a mixed receptor blocker as it blocks both alpha and beta receptors.

Exaprolol is a beta-adrenoceptor antagonist.